J 2021

Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review

VACULOVÁ, Jitka, Jiří DOLINA, Petr JABANDŽIEV, Martin ŠTĚRBA, Jiří TŮMA et. al.

Basic information

Original name

Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review

Authors

VACULOVÁ, Jitka (203 Czech Republic, belonging to the institution), Jiří DOLINA (203 Czech Republic, belonging to the institution), Petr JABANDŽIEV (203 Czech Republic, belonging to the institution), Martin ŠTĚRBA (203 Czech Republic, belonging to the institution), Jiří TŮMA (203 Czech Republic, belonging to the institution), Robert DOUŠEK (203 Czech Republic, belonging to the institution), Ladislav PLÁNKA (203 Czech Republic, belonging to the institution), Jan ŠENKYŘÍK (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution), Viera BAJČIOVÁ (703 Slovakia, belonging to the institution), Michal EID (203 Czech Republic, belonging to the institution), Zdeněk PAVLOVSKÝ (203 Czech Republic, belonging to the institution), Zdeněk KALA (203 Czech Republic, belonging to the institution) and Lumír KUNOVSKÝ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Klinická onkologie, Praha, Česká lékařská společnost J. E. Purkyně/Ambit Media, a. s. 2021, 0862-495X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/21:00120183

Organization unit

Faculty of Medicine

Keywords in English

inflamamtory pseudotumor; esophageal carcinoma; myofibroblastic tumor; plasma cell granuloma; endoscopy; surgery

Tags

Tags

International impact, Reviewed
Změněno: 21/12/2021 09:20, Mgr. Tereza Miškechová

Abstract

V originále

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm with intermediate malignant potential. Although most often seen in the lungs, it can occur at multiple anatomical locations, including the gastrointestinal tract. An esophageal lesion is extremely rare, however. IMTs present most commonly in children and young adults. The main therapeutic approach is surgical resection. Case report: We report on the follow-up of a case in a 13-year-old boy with IMT in the esophagus. He underwent surgical resection in 2013 and is free of disease to date. Conclusion: Surgical resection is the most preferred therapy. If the resection is complete, the risk of recurrence is low. Nevertheless, every patient should be carefully followed up after the resection.

Links

NU20-03-00126, research and development project
Name: Hostitelský mikrobiom ve vztahu k rozvoji Barrettova jícnu a adenokarcinomu jícnu
Investor: Ministry of Health of the CR, Host microbiome in relation to Barrett ́s esophagus and esophageal adenocarcinoma development, Subprogram 1 - standard